Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 38 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. Association of AFP with Hepatocellular Carcinoma Subtypes
    Callie Rose, James Hosner, Seung Hwan Chung +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  2. Therapeutic Strategies After Immunotherapy Failure in Advanced Non-Small Cell Lung Cancer: Mechanisms of Resistance and Emerging Treatment Approaches
    Masatoshi Kanayama, Masaru Takenaka, Hidetaka Uramoto
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Artificial Intelligence for Colorectal Cancer Diagnosis: A Comprehensive Survey of Modalities, Frameworks, and Clinical Tasks
    Bassant El-Mosalamy, Hossam Magdy Balaha, Sohayla El-Moursi +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  4. Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy
    Haruna Komatsubara, Shugo Mizuno, Daisuke Noguchi +10
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Treatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer
    Kevin M. Turner, Jason B. Gurewitz, Jessica M. Frakes +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  6. Synergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer
    Aditya K. Ghosh, Khalid A. Jazieh, Hao Xie +9
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  7. Reply to Gumustepe, A.; Gumustepe, E. Comment on “Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 3449”
    Barbara Giordani, Luigi Pirtoli, Guido Putignano +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  8. 3D Cultures and Organoids in Cancer Research
    César López-Camarillo, Karla Rubio
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  9. ANABOLIC FAILURE, NOT CATABOLIC ACTIVATION, UNDERLIES GLYCOGEN DEPLETION IN CERVICAL CARCINOGENESIS: A MULTI-COHORT TRANSCRIPTOMIC ANALYSIS
    O. O. Ajayi, E. B. Odigie, S. O. Adesite +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  10. SpatioCAD: Context-aware graph diffusion model for pinpointing spatially variable genes in heterogeneous tissues
    Hao Wen, Qunlun Shen, Shuqin Zhang
    PLOS Computational BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  11. A common pathogenic founder variant in Rwandan breast cancer cases
    Achille V. C. Manirakiza, Shakuntala Baichoo, Annette Uwineza +13
    PLOS GeneticsPeer-reviewedCC BY 4.0Full textOncologyPLOS
  12. Cohort Profile: The Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) longitudinal cohort of childhood cancer survivors in the United States
    Sara King-Dowling, Kelsey Woodard, Haley Faust +20
    PLOS OnePeer-reviewedCC BYFull textEpidemiology & public healthOncologyObstetrics, gynaecology & paediatricsPLOSEurope PMCPMC
  13. Prognostic value of the systemic inflammation response index (SIRI) in glioma: A meta-analysis
    Lixia Guo, Xudong Cao, Lijun Yang +3
    PLOS OnePeer-reviewedCC BYFull textNeurologyOncologyPLOSEurope PMCPMC
  14. Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study
    Kibir Temesgen Assefa, Abebaw Gebeyehu Worku, Achenef Asmamaw Muche +3
    PLOS OnePeer-reviewedCC BYFull textEpidemiology & public healthInfectious diseaseOncologyPLOSEurope PMCPMC
  15. Multiomic liquid biopsy: emerging applications in disease quantification, biomarker detection, molecular phenotyping, and cancer signal of origin prediction
    Jinesh S. Gheeya, Lauren Welch, Jason Porter +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  16. Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions
    Kanyadhara Lohita Krishna, Srinath B. S.
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  17. Chidamide combined with dinutuximab beta, irinotecan and temozolomide for relapsed or refractory neuroblastoma in children: protocol for a prospective, single-centre, open-label, single-arm, phase II study in China
    Yan Jin, Benfu Zhong, Jiarun Fu +14
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossrefPMC
  18. Impact of cervical cancer education on knowledge, attitudes and preventive practices among adolescent girls in secondary schools: a scoping review
    Karimat Itunu Jolayemi, Deborah Tolulope Esan, Oluwadamilare Akingbade +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyCrossref
  19. Role of METTL6 in gastric cancer: diagnostic, prognostic, and functional implications
    Dongdong Lu, Jie Lou, Leijie Huang +1
    PeerJPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  20. Lactylation-mediated remodeling of spatial immunometabolic niches in lung cancer: metabolic origins, cellular interactions, and molecular mechanisms
    Zihao Lin, Chengri Che, Shuwei Wang
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  21. Factors influencing parental hesitancy toward HPV vaccination in Sub-Saharan Africa: a scoping review
    Olajumoke Oluwakemi Opaleye, Deborah Tolulope Esan, Theophilus Olaide Esan +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  22. CT-based clinical deep learning radiomics nomogram for preoperative differentiation of pyelocaliceal upper tract urothelial carcinoma and xanthogranulomatous pyelonephritis
    Yi Feng, Yiheng Cheng, Jian Zeng +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  23. Effects of exercise interventions on cancer-related fatigue and quality of life in patients with metastatic breast cancer: a systematic review and meta-analysis
    Menghan Zhou, Lin Zou, Zhuangzhuang Sun +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  24. Multiplex immunohistochemistry in multiple myeloma: principles, spatial profiling applications, and emerging frontiers in immuno-oncology
    Di Zhou, Xiangyi Guo, Chenchen Wang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  25. Targeted alpha therapy for solid tumors: biological rationale, clinical advances, and future perspectives
    Qimin Li, Jian Xie, Fei Chen +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref